Tweet
With treatments for progressive MS few and far between, this is a promising finding. - Dave
January 31, 2012 — Results of a small proof-of-concept study hint that autologous mesenchymal stem cells may have neuroprotective effects in multiple sclerosis (MS).
The study involved 10 patients with secondary progressive MS and objective evidence of optic nerve involvement resulting from demyelination. Over the course of 6 to 10 months after a single infusion of autologous mesenchymal stem cells in the central nervous system (CNS), researchers saw evidence of functional, neurophysiological, and structural improvement in vision without evidence of significant adverse effects.
The patients also experienced a reduction in functional disability, as measured by the Expanded Disability Status Score (EDSS).
http://www.medscape.com/viewarticle/757809
(Login may be required, free)
More
http://www.thelancet.com/journals/la...305-2/abstract
The study involved 10 patients with secondary progressive MS and objective evidence of optic nerve involvement resulting from demyelination. Over the course of 6 to 10 months after a single infusion of autologous mesenchymal stem cells in the central nervous system (CNS), researchers saw evidence of functional, neurophysiological, and structural improvement in vision without evidence of significant adverse effects.
The patients also experienced a reduction in functional disability, as measured by the Expanded Disability Status Score (EDSS).
http://www.medscape.com/viewarticle/757809
(Login may be required, free)
More
http://www.thelancet.com/journals/la...305-2/abstract